ORLANDO, Fla. and DUBLIN, Jan. 26,
2015 /PRNewswire/ --
Dear Immune Therapeutics, Inc. (OTC-BB: IMUN) Shareholder:
I am writing today to update you on an important operational
change. ClearTrust, LLC, a leading stock transfer agent
serving growth companies and community banks, has acquired all
issuer accounts of Guardian Registrar & Transfer, Inc., our
transfer agent. As a result, ClearTrust is now Immune
Therapeutics' transfer agent and shareholder support
provider.
This change includes the transfer of your directly held shares
of Immune Therapeutics' common stock from Guardian Registrar &
Transfer to ClearTrust's platform. There is no action required
on your part for this transaction.
If you have any questions regarding your shares, please contact
a ClearTrust specialist by telephone at (813) 235-4490 or email at
inbox@ClearTrustTransfer.com. If you need to send documents
to ClearTrust, such documents can be emailed to the foregoing email
address, faxed to (813) 388-4549 or mailed to 16540 Pointe Village
Drive, Suite 210, Lutz, Florida
33558.
Thank you for your continued support of Immune Therapeutics.
Sincerely,
Noreen Griffin
Chief Executive Officer
Contact: Dennis S. Dobson
President and CEO
Dobson Media Group and
International Investor Relations Services Inc.
203-258-0159
www.dobsonmediagroup.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cleartrust-llc-is-immune-therapeutics-new-transfer-agent-and-support-provider-300025761.html
SOURCE Immune Therapeutics, Inc.